ArticleLung cancer (Amsterdam, Netherlands)2025

Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).

Yuji Uehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.